RT Journal Article
SR Electronic
T1 Forecasting the SARS-CoV-2 effective reproduction number using bulk contact data from mobile phones
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.02.20188136
DO 10.1101/2020.10.02.20188136
A1 Sten Rüdiger
A1 Stefan Konigorski
A1 Jonathan Edelman
A1 Detlef Zernick
A1 Alexander Thieme
A1 Christoph Lippert
YR 2020
UL http://medrxiv.org/content/early/2020/12/11/2020.10.02.20188136.abstract
AB Over the last months, cases of SARS-CoV-2 surged repeatedly in many countries and could often be controlled with non-pharmaceutical interventions such as social distancing. We analyzed de-identified GPS tracking data from 1.15 to 1.4 million cell phones in Germany per day between March-November 2020 to identify encounters between individuals and statistically evaluate large-scale contact behavior. Using graph sampling theory we estimated the contact index (CI), a metric for number and heterogeneity of contacts and found that the contact index, and not the total number of contacts, is an accurate predsictor for the effective reproduction number R. A high correlation between CI and R occurring more than two weeks later allows timely assessment of the social behavior well before the infections become detectable. The CI quantifies the role of superspreading and allows assigning risks to specific contact behavior. We provide a critical CI-value beyond which R is expected to rise above 1 and propose to use it to leverage the social distancing interventions for the coming months.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project has been initiated within the initiative Mittelstand-digital of the German Federal Ministry of Economic Affairs (BMWi), in the \_Gemeinsam digital, the Mittelstand 4.0 Centre of Excellence Berlin.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:naAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesna